86 related articles for article (PubMed ID: 29466694)
1. Lipid pathway deregulation in advanced prostate cancer.
Galbraith L; Leung HY; Ahmad I
Pharmacol Res; 2018 May; 131():177-184. PubMed ID: 29466694
[TBL] [Abstract][Full Text] [Related]
2. Tannic acid inhibits lipid metabolism and induce ROS in prostate cancer cells.
Nagesh PKB; Chowdhury P; Hatami E; Jain S; Dan N; Kashyap VK; Chauhan SC; Jaggi M; Yallapu MM
Sci Rep; 2020 Jan; 10(1):980. PubMed ID: 31969643
[TBL] [Abstract][Full Text] [Related]
3. Effect of strontium on transcription factors identified by transcriptome analyses of bovine ruminal epithelial cells.
Tan P; Wang Y; Mei L; Loor JJ; Zhao C; Kong Y; Zeng F; Zhao B; Wang J
BMC Vet Res; 2024 Mar; 20(1):88. PubMed ID: 38459489
[TBL] [Abstract][Full Text] [Related]
4. Integrated investigation and experimental validation of PPARG as an oncogenic driver: implications for prognostic assessment and therapeutic targeting in hepatocellular carcinoma.
Ran Y; Hu C; Wan J; Kang Q; Zhou R; Liu P; Ma D; Wang J; Tang L
Front Pharmacol; 2023; 14():1298341. PubMed ID: 38044948
[TBL] [Abstract][Full Text] [Related]
5. Regulation and targeting of SREBP-1 in hepatocellular carcinoma.
Su F; Koeberle A
Cancer Metastasis Rev; 2023 Dec; ():. PubMed ID: 38036934
[TBL] [Abstract][Full Text] [Related]
6. Radiotranscriptomics identified new mRNAs and miRNA markers for distinguishing prostate cancer from benign prostatic hyperplasia.
Yang Q; Li Q; Li N; Wang D; Niu S; Tang P; Xiao J; Zhao J; Wang P; Luo Y; Tang J
Cancer Med; 2023 Dec; 12(24):21694-21708. PubMed ID: 37987209
[TBL] [Abstract][Full Text] [Related]
7. Targeting DGAT1 inhibits prostate cancer cells growth by inducing autophagy flux blockage via oxidative stress.
Cui H; Wang Y; Zhou T; Qu L; Zhang X; Wang Y; Han M; Yang S; Ren X; Wang G; Gang X
Oncogene; 2024 Jan; 43(2):136-150. PubMed ID: 37973951
[TBL] [Abstract][Full Text] [Related]
8. Exosome and lipid metabolism-related genes in pancreatic adenocarcinoma: a prognosis analysis.
Wu J; Li Y; Nabi G; Huang X; Zhang X; Wang Y; Huang L
Aging (Albany NY); 2023 Oct; 15(20):11331-11368. PubMed ID: 37857015
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Expression Levels of NFATc2 and PPARG Genes Two Effector Elements of WNT Pathway in Non-Small Cell Lung Carcinoma.
Motamediyan K; Zafari V; Bornehdeli S; Caner A; Asadi M; Hashemzadeh S; Firozi MR; Raeisi M
Adv Biomed Res; 2023; 12():184. PubMed ID: 37694246
[TBL] [Abstract][Full Text] [Related]
10. Ultrastructural analysis of prostate cancer tissue provides insights into androgen-dependent adaptations to membrane contact site establishment.
Butler LM; Evergren E
Front Oncol; 2023; 13():1217741. PubMed ID: 37529692
[TBL] [Abstract][Full Text] [Related]
11. Anti-Obesity Effect and Mechanism of Chitooligosaccharides Were Revealed Based on Lipidomics in Diet-Induced Obese Mice.
Zhou M; Huang J; Zhou J; Zhi C; Bai Y; Che Q; Cao H; Guo J; Su Z
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513467
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor knockdown enhances prostate cancer chemosensitivity by down-regulating FEN1 through the ERK/ELK1 signalling pathway.
Xie W; Li S; Guo H; Zhang J; Tu M; Wang R; Lin B; Wu Y; Wang X
Cancer Med; 2023 Jul; 12(14):15317-15336. PubMed ID: 37326412
[TBL] [Abstract][Full Text] [Related]
13. New insights into lipid metabolism and prostate cancer (Review).
Zhang Z; Wang W; Kong P; Feng K; Liu C; Sun T; Sang Y; Duan X; Tao Z; Liu W
Int J Oncol; 2023 Jun; 62(6):. PubMed ID: 37203395
[TBL] [Abstract][Full Text] [Related]
14. Multi-omics profiling of PC-3 cells reveals bufadienolides-induced lipid metabolic remodeling by regulating long-chain lipids synthesis and hydrolysis.
Zhang R; Zhang Z; Wu W; Shi J; Berk E; Li W; Deng Y; Wang Z; Hou J; Long H; Lei M; Wu W
Metabolomics; 2023 Jan; 19(2):6. PubMed ID: 36645548
[TBL] [Abstract][Full Text] [Related]
15. Chaihu-Shugan-San ameliorates tumor growth in prostate cancer promoted by depression
Li W; Zhou R; Zheng J; Sun B; Jin X; Hong M; Chen R
Front Pharmacol; 2022; 13():1011450. PubMed ID: 36545317
[No Abstract] [Full Text] [Related]
16. The role of PPARγ in prostate cancer development and progression.
Hartley A; Ahmad I
Br J Cancer; 2023 Apr; 128(6):940-945. PubMed ID: 36510001
[TBL] [Abstract][Full Text] [Related]
17. A ferroptosis-inducing biomimetic nanocomposite for the treatment of drug-resistant prostate cancer.
Chen J; Wang Y; Han L; Wang R; Gong C; Yang G; Li Z; Gao S; Yuan Y
Mater Today Bio; 2022 Dec; 17():100484. PubMed ID: 36388460
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of a lipid metabolism gene signature for predicting biochemical recurrence of prostate cancer after radical prostatectomy.
Cai Y; Lin J; Wang Z; Ma Y; Pan J; Liu Y; Zhao Z
Front Oncol; 2022; 12():1009921. PubMed ID: 36324578
[TBL] [Abstract][Full Text] [Related]
19. The interplay of transcriptional coregulator NUPR1 with SREBP1 promotes hepatocellular carcinoma progression via upregulation of lipogenesis.
Wang Y; Zhang Y; Wang Z; Yu L; Chen K; Xie Y; Liu Y; Liang W; Zheng Y; Zhan Y; Ding Y
Cell Death Discov; 2022 Oct; 8(1):431. PubMed ID: 36307402
[TBL] [Abstract][Full Text] [Related]
20. Effects of scoparone on non-alcoholic fatty liver disease revealed by RNA sequencing.
Huang X; Gao Y; Cao H; Li J; Mo S; Li T; Wu J; Guo K; Wei R; Zhang K
Front Endocrinol (Lausanne); 2022; 13():1004284. PubMed ID: 36157436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
